When It Comes to Raising Vitamin D Levels, Anesthesiologists Advised—"Don't Be Wimpy!"
Editorial Calls for Bold Action While Awaiting Definitive Vitamin D Trials
Article ID: 622305
Released: 21-Aug-2014 9:40 AM EDT
Source Newsroom: Wolters Kluwer Health: Lippincott Williams and Wilkins
Newswise — August 21, 2014 – Enough observational studies—it's time for doctors to recommend steps to raise their patients' vitamin D levels. That's the message in a provocative editorial published in Anesthesia & Analgesia.
There's already enough evidence to justify increasing vitamin D levels to improve health, according to the opinion piece by Drs Michael F. Roizen of the Cleveland Clinic and Jeffrey D. Roizen of Children's Hospital of Philadelphia. Meanwhile, they propose a randomized trial to conclusively determine whether vitamin D can reduce complication rates after surgery.
Don't Wait for Further Research—Act Now to Increase Vitamin D LevelsThe father-and-son coauthors write in response to the latest research paper reporting linking higher vitamin D levels to better health outcomes. In that study—also published in Anesthesia & Analgesia—Dr Alparslan Turan and colleagues of the Cleveland Clinic found that surgical patients with higher vitamin D had lower rates of death and complications after surgery.
While the observational study shows significant associations, it can't prove a cause-and-effect relationship. Dr Turan and coauthors suggest a cautious approach to further research, starting with more observational data on the relationship between preoperative vitamin D levels and postoperative outcomes.
But Drs Roizen and Roizen strongly disagree, writing: "What a wimpy conclusion." While acknowledging the limitations of observational studies, they point out that a long series of studies has linked vitamin D to "a cornucopia of improved health outcomes." These include "improved bone health, fewer falls, fewer bone fractures, reduced risk of heart attack and stroke, reduced risk of, and death from, colon, breast, and prostate cancer"—among others.
They believe the research warrants moving forward with a formal study evaluating the benefits of vitamin D supplementation before surgery. Citing the storied history of advances in clinical care by anesthesiologists, Drs Roizen and Roizen write, "Let's continue to take bold steps to improve outcome….Let's determine whether vitamin D is just a fireman (showing up at every fire, but seldom causing them), or has some real fire power in improving perioperative outcomes.
They propose a randomized trial to determine whether giving vitamin D supplements for two or three weeks before scheduled surgery can decrease complication rates. Among the questions to be answered are what vitamin D levels have the most benefit with the lowest potential for harm—recommendations range from 20 to 50 nanograms per milliliter (ng/mL). Ideally, the study would include groups with vitamin D levels or 20, 35, and 50 ng/mL.
But patients shouldn't wait for the results of clinical trials before taking "reasonable" steps to ensure adequate vitamin D levels, Drs Roizen and Roizen believe. They recommend that patients ask their doctor what their vitamin D level is and whether they need more. For patients with vitamin D levels less than 50 ng/mL, they recommend taking supplements to get more vitamin D2 and D3. They note that it takes six weeks to achieve a steady-state vitamin D level.
The Roizens add that doctors aren't immune to low vitamin D. They have checked their own vitamin D levels, and believe that other physicians—including anesthesiologists—should consider doing so as well. They conclude, "No matter what you decide for yourself, let us be bold (and beneficial to the rest of medicine and our patients) as a specialty."
About Anesthesia & AnalgesiaAnesthesia & Analgesia was founded in 1922 and was issued bi-monthly until 1980, when it became a monthly publication. A&A is the leading journal for anesthesia clinicians and researchers and includes more than 500 articles annually in all areas related to anesthesia and analgesia, such as cardiovascular anesthesiology, patient safety, anesthetic pharmacology, and pain management. The journal is published on behalf of the IARS by Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health.
About the IARSThe International Anesthesia Research Society is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes nearly $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 15,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia related practice; sponsors the SmartTots initiative in partnership with the FDA; and publishes the monthly journal Anesthesia & Analgesia in print and online.
About Wolters Kluwer HealthWolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health’s market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Follow our official Twitter handle: @WKHealth.